- Home
- WERN vs CERT Comparison
WERN vs CERT Comparison
Compare WERN & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WERN
- CERT
- Stock Information
- Founded
- WERN 1956
- CERT 2008
- Country
- WERN United States
- CERT United States
- Employees
- WERN N/A
- CERT N/A
- Industry
- WERN Trucking Freight/Courier Services
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- WERN Industrials
- CERT Technology
- Exchange
- WERN Nasdaq
- CERT Nasdaq
- Market Cap
- WERN 2.0B
- CERT 2.3B
- IPO Year
- WERN N/A
- CERT 2020
- Fundamental
- Price
- WERN $29.33
- CERT $9.91
- Analyst Decision
- WERN Hold
- CERT Buy
- Analyst Count
- WERN 15
- CERT 6
- Target Price
- WERN $36.60
- CERT $15.80
- AVG Volume (30 Days)
- WERN 891.9K
- CERT 1.2M
- Earning Date
- WERN 04-29-2025
- CERT 05-06-2025
- Dividend Yield
- WERN 1.91%
- CERT N/A
- EPS Growth
- WERN N/A
- CERT N/A
- EPS
- WERN 0.55
- CERT N/A
- Revenue
- WERN $3,030,258,000.00
- CERT $385,148,000.00
- Revenue This Year
- WERN $4.25
- CERT $11.44
- Revenue Next Year
- WERN $7.60
- CERT $8.90
- P/E Ratio
- WERN $53.54
- CERT N/A
- Revenue Growth
- WERN N/A
- CERT 8.70
- 52 Week Low
- WERN $28.77
- CERT $9.41
- 52 Week High
- WERN $42.48
- CERT $19.18
- Technical
- Relative Strength Index (RSI)
- WERN 32.60
- CERT 26.70
- Support Level
- WERN $28.77
- CERT $10.21
- Resistance Level
- WERN $30.35
- CERT $11.12
- Average True Range (ATR)
- WERN 0.76
- CERT 0.49
- MACD
- WERN 0.11
- CERT -0.05
- Stochastic Oscillator
- WERN 17.34
- CERT 14.20
About WERN Werner Enterprises Inc.
Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - TTS and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.